Your browser doesn't support javascript.
loading
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma.
Galettis, Peter; Cheah, Chan Y; Davis, Joanne; Ludford-Menting, Mandy; Link, Emma K; Martin, Jennifer H; Koldej, Rachel; Ritchie, David.
Afiliação
  • Jake Shortt; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia. jake.shortt@monash.edu.
  • Galettis P; Monash Haematology, Monash Health, Clayton, VIC, Australia. jake.shortt@monash.edu.
  • Cheah CY; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. jake.shortt@monash.edu.
  • Davis J; Centre for Drug Repurposing and Medicines Research, University of Newcastle, Callaghan, NSW, Australia.
  • Ludford-Menting M; Hunter Medical Research Institute, Kookaburra Circuit, New Lambton Heights, NSW, Australia.
  • Link EK; Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • Martin JH; Division of Internal Medicine, Medical School, University of Western Australia, Perth, WA, Australia.
  • Koldej R; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Ritchie D; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
Clin Epigenetics ; 15(1): 15, 2023 01 28.
Article em En | MEDLINE | ID: mdl-36709310
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Epigenetics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Epigenetics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália